Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pandefense Advisory is a private public-health and pandemic-response advisory firm that supports organizations across the private, public, philanthropic, and nonprofit sectors. The company focuses on strategic guidance, epidemiology-informed risk assessment, forecasting, workplace health and safety, and translation of evolving public-health guidance and regulation into operational plans. Its network includes experts in epidemiology, infectious diseases, public health, data science, and policy, and it has been led by founder and CEO Dr. Larry Brilliant. Rather than operating a therapeutic pipeline, Pandefense provides consulting services related to Covid-19 response, future outbreak preparedness, and broader health-risk management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pandefense Advisory.